Site Contracts: a Global Assessment From KMR Group
Published: Apr 11, 2012
The survey not only shows each company how their site contracting process compares with other major companies in the industry, but also provides context around more qualitative site contracting practices such as use of master agreements, payment strategies, timing and terms.
Site contract performance is being analyzed from a number of perspectives including the type of site (independent, institution), study phase, therapy area and geography. As this is the third time KMR is conducting this study, the results will also include trends over time.
“Faster contracting times translate into faster study start-up, the most time consuming portion of a clinical trial. By providing companies with reliable, detailed site contract benchmarks as well as an assessment of their own performance, the study will provide each company with information they can directly employ to enhance their site contract strategies and performance improvement efforts,” commented Linda Martin, Principal of KMR Group.
For further information contact:
Lyndsey McKay, Marketing Manager Tel: +1 (312) 795-0400 Email: email@example.com
KMR has been working exclusively in the biopharmaceutical R&D industry since the early 1990s. KMR is a leader in benchmarking, analytics and performance management. With an exclusive focus on biopharmaceutical R&D and unrivaled commitment to data quality, KMR provides industry with the experience and knowledge to produce clear and uncompromising results in the form of reports, tools and presentations. We use our extensive, unparalleled datasets and experience within the industry to add value to the most pressing business questions. Please visit our website at http://kmrgroup.com
150 North Wacker Drive, Suite 1070 Chicago, Illinois 60606 USA
Copyright © KMR Group 2012 All rights reserved.